| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |